3,4-Methylenedioxy-N-hydroxy-N-methylamphetamine
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C11H15NO3 |
Molar mass | 209.245 g·mol−1 |
3D model (JSmol) | |
SMILES
|
3,4-Methylenedioxy-N-hydroxy-N-methylamphetamine (MDHMA; FLEA) is an entactogen, psychedelic, and stimulant of the phenethylamine and amphetamine chemical classes. It is the N-hydroxy homologue of MDMA ("Ecstasy"), and the N-methyl homologue of MDOH. MDHMA was first synthesized and assayed by Alexander Shulgin.[1] In his book PiHKAL (Phenethylamines i Have Known And Loved), Shulgin listed the dosage range as 100–160 mg, and the duration as approximately 4–8 hours.[1] He describes MDHMA as causing entactogenic and open MDMA-like effects, easing communication, and increasing appreciation of the senses.[1]
Legality[]
United Kingdom[]
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]
References[]
- ^ a b c Shulgin A, Shulgin A (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
- ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.
External links[]
Categories:
- Substituted amphetamines
- Designer drugs
- Benzodioxoles
- Serotonin-norepinephrine-dopamine releasing agents
- Methamphetamines
- Entactogens and empathogens
- Hydroxylamines